Cargando…
Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines
Botulinum toxin type A (BTX-A) preparations are widely used nonsurgical treatments for facial wrinkles. Higher doses of BTX-A are also used for therapeutic purposes in the treatment of conditions involving increased muscle tone, such as cervical dystonia. The phenomenon of antibody-induced treatment...
Autores principales: | Stengel, Gabriele, Bee, Eva Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230581/ https://www.ncbi.nlm.nih.gov/pubmed/22162643 http://dx.doi.org/10.2147/CIA.S18997 |
Ejemplares similares
-
Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
por: Kaufman-Janette, Joely, et al.
Publicado: (2021) -
Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines
por: Yi, Kyu-Ho, et al.
Publicado: (2022) -
Botulinum toxin type-A in the treatment of glabellar lines
por: Winter, Leslie, et al.
Publicado: (2009) -
Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation
por: Kim, Soo-Bin, et al.
Publicado: (2021) -
Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
por: Prager, Welf
Publicado: (2013)